LifeMD, Inc. (LFMD)
NASDAQ: LFMD · IEX Real-Time Price · USD
6.55
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
6.60
+0.05 (0.76%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
LifeMD Market Cap
LifeMD has a market cap or net worth of $273.51 million as of July 22, 2024. Its market cap has increased by 102.30% in one year.
Market Cap
273.51M
Enterprise Value
258.30M
1-Year Change
102.30%
Ranking
Category
Stock Price
$6.55
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $273.51M, an increase of 7,714.43%. That is a compound annual growth rate of 47.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 277.00M | -12.01% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
| Apr 1, 2013 | 3.50M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alimera Sciences | 292.07M |
| Tactile Systems Technology | 291.56M |
| Orchestra BioMed Holdings | 291.32M |
| Omeros | 289.43M |
| Aquestive Therapeutics | 286.32M |
| AngioDynamics | 283.19M |
| Akebia Therapeutics | 278.76M |
| Zentalis Pharmaceuticals | 274.82M |